Join to access to all OVN content. Join for Free
The Struggle With KOL Access in Todays World
KOL access medical affairs AI in healthcare hybrid model MSL relationships

The Struggle With KOL Access in Todays World


Share This Article


Summary

Carsten Schnatwinkel and Jeanna Cooper join Tom Caravela to discuss the evolving landscape of KOL access in medical affairs. They address challenges in securing KOL access and the role of AI and digital tools in overcoming these barriers. The conversation explores the hybrid model's significance, the impact of virtual engagement on key performance indicators, and strategies for building strong KOL relationships. They also examine geographic and therapeutic variations, persistence and resilience strategies, and the importance of follow-up. The episode concludes with practical tips for increasing face time with KOLs and utilizing social media effectively.

Key Points

  • MSLs face significant challenges in gaining access to KOLs due to virtual preferences, increased digital resources, and the rise of telemedicine, making it crucial to maximize the value of in-person meetings and collaborate with cross-functional partners.
  • Virtual engagements offer convenience but lack the relationship-building benefits of face-to-face interactions, suggesting a hybrid model is essential for effective MSL-KOL interactions.
  • Demonstrating value through concise, impactful communication, thorough preparation, and proactive follow-up is critical for MSLs to establish and maintain strong relationships with KOLs, especially in a competitive and evolving healthcare landscape.

Click for Source
KOL access, medical affairs, AI in healthcare, hybrid model, MSL relationships

Related Topics

Meet Our Innovation Partners

Loading partners...

You May Also Like

Article
Empowering people to drive medical affairs performance with AI
Partner Avatar Envision Pharma Group

Empowering people to drive medical affairs performance with AI

Article
Medical affairs: The power behind redefining commercialization
Partner Avatar Envision Pharma Group

Medical affairs: The power behind redefining commercialization

Podcast
Interim Impact The Rise of Fractional Medical Affairs Roles in Pharmas New Reality
Partner Avatar MSL Talk: Tom Caravela, Daniel Snyder

Interim Impact The Rise of Fractional Medical Affairs Roles in Pharmas New Reality

Podcast
From Interactions to Impact: How Medical Affairs Can Prove Its Value
Partner Avatar MLS Talk: Tom Caravela, Lusine Kodagolian

From Interactions to Impact: How Medical Affairs Can Prove Its Value

Article
Methodological and reporting standards for quality-of-life data eligible for European Society for Medical Oncology-Magnitude of Clinical Benefit Scale
OVN Avatar S.F. Oosting, J. Barriuso, A. Bottomley, M. Galotti, B. Gyawali, B. Kiesewetter, N.J. Latino, F. Martinelli, M. Pe, G. Pentheroudakis, F. Roitberg, H. Vachon, E.G.E. de Vries, M. Piccart, N.I. Cherny

Methodological and reporting standards for quality-of-life data eligible for European Society for Medical Oncology-Magnitude of Clinical Benefit Scale

Article
Sponsorship of oncology clinical trials in the United States according to age of eligibility
OVN Avatar Dylan V Neel, David S Shulman, Clement Ma, Florence Bourgeois, Steven G DuBois

Sponsorship of oncology clinical trials in the United States according to age of eligibility

Explore OVN